PharmaShots | Incisive News in 3 Shots

Subscribe Now

organophosphate exposure

Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure

Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure

December 17, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us